Search result

National Contract Value Review

The national contract value review (NCVR) is a standardised, national approach to costing for commercial contract research From 14 October 2024, NCVR will include Early Phase (phase I and IIa) and Advanced Therapeutic Medicinal Products (ATMPs) studies. Since its introduction across the UK in 2023 it has helped speed up commercial research set up times, making the UK a more attractive place for commercial organisations to undertake research studies, ensuring UK patients have e...

View Page

Get Involved

Glasgow Clinical Research Facility (GCRF) believes in a model of integrated public engagement, patient involvement and research participation – by working together to improve healthcare through research. It is our aim to make research involvement as accessible as possible and have a wide range of patients and public/lay representatives to steer our research and support researchers to identify and conduct high-quality clinical research. Learn more about participating in res...

View Page

UK-wide Working

A combined IRAS Form that merged the REC and R&D Forms has been used since March 2016 for research projects where the lead NHS R&D office is based in England. For research projects created in IRAS from the evening of 28 June 2017, the single IRAS Form will also be used in place of separate REC and R&D Forms for projects where the lead NHS/HSC R&D office is based in Northern Ireland, Scotland or Wales. Projects already in the system will continue to use separate forms. R...

View Page

Scottish Diabetes Data Provisioning for Research, Innovation and Audit

Many diabetes research, innovation or audit projects are now seeking controlled access to the unique data sets available from SCI-Diabetes, NHS Scotland’s electronic patient record for diabetes.   The NHS Research Scotland (NRS) Diabetes Network acts as the initial contact for guiding and supporting diabetes data provisioning. A comprehensive basic guide for data provision is available upon request....

View Page

Imaging Capability

Scotland was the birthplace of medical ultrasound imaging and MRI and works hard to maintain its position of excellence. SINAPSE, a partnership of six Scottish Universities - Edinburgh, Aberdeen, Dundee, Glasgow, St Andrews and Stirling - make best use of Scottish facilities and expertise in medical imaging and develop skills for the next generation of professionals working in this field. Scottish researchers have access to all im...

View Page

Pain

The Scottish Pain Research Community (SPaRC) was established in 2009 with support from the Scottish Government to develop expertise in pain research for patient benefit. A strong network of pain researchers, clinicians, third-sector organisations, patient groups and other key stakeholders across Scotland support internationally competitive pain research. This covers the full scientific range, from laboratory to the communit...

View Page

Dr Bhautesh Jani

View Page

Patient and Public Involvement

NHS Research Scotland's Mental Health Network plays a central role in supporting mental health research of all kinds in Scotland.  Our Patient and Public Involvement (PPI) Strategy, soon to be published, will lay out the outcomes we hope to achieve within the field of PPI over the next few years.  What does Patient and Public Involvement mean?  Patient and public involvement in research means research that is done 'with' or 'by' the public, not 'to', 'abo...

View Page

Project Updates

The four UK nations are committed to making it easier to carry out research in the UK. The aim is to make the researcher experience of study set up the same across the UK. Working together, England, Northern Ireland, Scotland and Wales are developing compatible cross-border processes. If you have any queries about the programme, please contact the operational lead for your nation.  

View Page

Patient and public involvement in mental health

Over the past decade, the role of patient and public involvement (PPI) in mental health research has grown enormously as its value to research excellence has been recognised and accepted. Over the past few years, PPI has cemented itself as both a core value of high quality clinical research and an intrinsically important part of any successful and well-regarded clinical research trial.   -------------------------------------- The

View Page